CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 25.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $416,000 | – | 97,688 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,356,091 | $1,202,000 | 0.05% |
| VANGUARD GROUP INC | 6,177,466 | $156,921,000 | 0.01% |
| SHUFRO ROSE & CO LLC | 17,500 | $8,000 | 0.00% |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 12,000 | $6,000 | 0.00% |
| PACIFIC GLOBAL INVESTMENT MANAGEMENT CO | 10,000 | $5,000 | 0.00% |
| Glassman Wealth Services | 2,197 | $1,000 | 0.00% |
| Krilogy Financial LLC | 600 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,856 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 33,166 | $17,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 86,435 | $44,000 | 0.00% |